Patents Assigned to SABIN VACCINE INSTITUTE
  • Chimpanzee adenoviral vector-based filovirus vaccines
    Patent number: 11913013
    Abstract: This invention provides vaccines for inducing an immune response and protection against filovirus infection for use as a preventative vaccine in humans. In particular, the invention provides chimpanzee adenoviral vectors expressing filovirus proteins from different strains of Ebolavirus (EBOV) or Marburg virus (MARV).
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: February 27, 2024
    Assignee: SABIN VACCINE INSTITUTE
    Inventors: Nancy J. Sullivan, Gary J. Nabel, Clement Asiedu, Cheng Cheng, Alfredo Nicosia, Riccardo Cortese, Virginia Ammendola, Stefano Colloca